高级搜索
骨肿瘤患者血液LPO SOD GSH-PX与GSH临床价值的初步探讨[J]. 肿瘤防治研究, 1994, 21(1): 38-40.
引用本文: 骨肿瘤患者血液LPO SOD GSH-PX与GSH临床价值的初步探讨[J]. 肿瘤防治研究, 1994, 21(1): 38-40.
A PRELIMINARY STUDY OF CLINICAL VALUE OF BIOOD LPO,SOD,GSH-PXAND GSH IN PATIENTS WITH OSTEOMA[J]. Cancer Research on Prevention and Treatment, 1994, 21(1): 38-40.
Citation: A PRELIMINARY STUDY OF CLINICAL VALUE OF BIOOD LPO,SOD,GSH-PXAND GSH IN PATIENTS WITH OSTEOMA[J]. Cancer Research on Prevention and Treatment, 1994, 21(1): 38-40.

骨肿瘤患者血液LPO SOD GSH-PX与GSH临床价值的初步探讨

A PRELIMINARY STUDY OF CLINICAL VALUE OF BIOOD LPO,SOD,GSH-PXAND GSH IN PATIENTS WITH OSTEOMA

  • 摘要: 本文对29例恶性骨肿瘤、38树良性骨肿瘤,21例非瘤骨疾病患者血浆脂质过氧化物(LPO)、全血超氧化物歧化酶(SOD),谷胱甘肽过氧化物酶(GSH一PX),及谷胱甘肽(GSH)进行测定,结果显示:在恶性,良性骨肿瘤与非瘤骨疾病比较、SOD(P<0.01)、GSH(P<0.05)均有显著差异.LPO值在非瘤骨疾病、良性及恶性骨肿瘤是升高趋势,各组比较无显著差异,(P>0.05).良性、恶性骨肿瘤与非瘤骨疾病的四个项目进行逐步判别分析、LPO,SOD二项灵敏性94.03%.特异性38.1%,它可供临床辅助诊断参考.

     

    Abstract: This paper deals with the determination of lipoperoxides (LPO) in plasma, superokide dismustase(SOD),Glutathion peroxidase (GSH-PX) and Glutathion (GSH) in blood in 29 cases withmalignant osteoma, 38 cases with benign osteoma and 21 cases with non-tumorous disease of bone,The results showed that both SOD and GSH differed significantly (P0.01 for SOD and P0.05for GSH) in malignant osteoma, benign osteoma and nontumorous disease of bone,while conentof plasma LPO tended to increase in all three groups with no significant difference (P0. 05). Astepwise discriminant analysis of these four indices in the three groups indicated a sensitivity of94.03% and a specificity of 38. 1% in combined LPO and SOD. This can be used as clinical accessory diagnosis.

     

/

返回文章
返回